Stay updated on Risankizumab in PsA Patients: Clinical Trial
Sign up to get notified when there's something new on the Risankizumab in PsA Patients: Clinical Trial page.

Latest updates to the Risankizumab in PsA Patients: Clinical Trial page
- CheckyesterdayChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedRevision tag updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.0%

- Check37 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.0%

- Check59 days agoChange DetectedMinor website revision updates were made: Revision v3.4.2 was added and Revision v3.4.1 was removed. No user-facing content or study data were altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check66 days agoChange DetectedAdded Revision: v3.4.1 and removed the previous notices (Revision: v3.4.0) related to government funding and operating status.SummaryDifference0.1%

- Check73 days agoChange DetectedAdded a government funding lapse notice at the top with links to cc.nih.gov and opm.gov, and added a 2025 Arthritis Research & Therapy article citation by Gossec et al. on risankizumab in PsA while removing the online-ahead-of-print note for that citation.SummaryDifference0.1%

Stay in the know with updates to Risankizumab in PsA Patients: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risankizumab in PsA Patients: Clinical Trial page.